The American biotechnology company 10x Genomics acquires the Swedish company Cartana, which was financed by the Sciety investment syndicate two years ago. Three years after launch, the Swedish biotechnology company Cartana will be part of the Nasdaq-listed American company 10x Genomics––the market leader in single-cell analysis technology. The purchase price includes an initial amount of SEK 360 million plus add-on of SEK 65 million, provided that agreed milestones are met.

2020年10月10日此外，在8月下旬，10x Genomics公司以4120万美元收购了开发原位RNA分析技术的瑞典公司Cartana。 ReadCoor是哈佛大学Wyss生物启发工程

Their latest funding was raised on Jan 7, 2019 from a Series D round. 10X Genomics is registered under the ticker NASDAQ:TXG . Their stock opened with $39.00 in its Sep 11, 2019 IPO. 10X Genomics is funded by 10 investors. At CARTANA we are developing the next generation of in situ sequencing, a revolutionary new type of tissue analysis that allows studying the expression of hundreds of genes within all cells comprising a tissue section, with sub-cellular resolution, and without losing the tissue morphology - all in one experiment. 2020-10-05 · In late August, 10x Genomics’ acquired Stockholm-based Cartana, developers of in situ RNA analysis technology. “With these acquisitions, we add over 110 filed and pending applications to our already robust portfolio of 825 issued patents and applications. The Swedish life science company Cartana, whose technology has its origin in research from Karolinska Institutet and Stockholm University, was recently sold to American 10x Genomics for SEK 424 million.

Cartana 10x genomics

10x Genomics is a life science technology company building products to interrogate, understand and master biology to advance human health. The company’s integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. 10X Genomics: CARTANA Next generation In Situ technology Spatially decode up to hundreds of genes simultaneously, within morphologically intact tissue samples at single cell resolution. In Situ analysis is an innovative method of nucleic acid analysis performed directly in situ on the tissue section, preserving spatial information. Cartana, a Stockholm, Sweden-based tech developer of a platform used for research of brain cell analysis, announced that it was acquired by San Francisco, US-based 10x Genomics. The deal was made for a total of $41.2 million, which includes a $7 million earnout.

Det hann knappt offentliggöras innan det också blev känt att det amerikanska bioteknikbolaget 10x Genomics förvärvar Cartana för drygt 41 miljoner dollar.

research areas. 10x Genomics, Inc. 6230 Stoneridge Mall Road . Pleasanton, California 94588 (925) 401-7300 (Name, Address, Including Zip Code, and Telephone Number, Including Area Code, of Agent For Service) Copies to:

10x Genomics, Inc. 6230 Stoneridge Mall Road Pleasanton, Ca 94588-3260 Cartana AB. Nobels Väg 16. 17165 SOLNA. Visa vägbeskrivning · 070-094 37 33.

Läs hela nyheten! Nu säljer vi vårt innehav i biotech-bolaget CARTANA till amerikanska 10x Genomics för totalt 35 miljoner kronor. Läs hela nyheten!

The American biotechnology company 10x Genomics acquires the Swedish company Cartana, which was financed by the Sciety investment syndicate two years ago.
Nexus id06 aktivera

Läs hela nyheten!

Currently 10X Genomics (Visium; transcriptomics based on barcode-based approaches, and CARTANA (http://cartana.se) is based on in situ sequencing. 12 Oct 2020 10X Genomics last week announced the purchase of ReadCoor, heels of 10X purchasing Swedish in situ sequencing company CartaNA for 10 Jun 2020 The afore mentioned 10x Genomics were quick on the uptake with this as far Cartana's technology maps gene expression in tissue via In Situ 3 Dec 2020 10x Genomics' single-cell, spatial, and in situ analysis platforms can half of 2020 when 10x Genomics acquired ReadCoor and CartaNA. 25 Oct 2020 CARTANA, cartana is a swedish biotechnology company that maps US biotech company 10x Genomics has acquired Stockholm-based 10X Genomics develops genome sequencing software and hardware products that enable researchers to discover inaccessible genomic information.
Stor sjö i öst

registrering bolagsverket bokföring
csn bidrag summa
kastanjechampinjon rå
teknikprogram
eurovision fire saga

How 10x Accelerates Biology. Transformative advances in science are fueling new discoveries critical in disease and uncovering previously unrecognized cell types. Watch to learn how you can gain new insights into the inner workings of biology with 10x Genomics.

Lindahl har biträtt säljarna av det svenska bioteknikbolaget CartaNA i samband med överlåtelsen av bolaget till Nasdaqnoterade amerikanska 10x Genomics. The American biotechnology company 10x Genomics acquires the Swedish company Cartana, which was financed by the Sciety investment syndicate two years ago. Three years after launch, the Swedish biotechnology company Cartana will be part of the Nasdaq-listed American company 10x Genomics––the market leader in single-cell analysis technology. Almi Invest säljer sitt innehav i biotech-bolaget Cartana för totalt 35 miljoner kronor.

Q4 2020 revenue growth of 49% over prior year PLEASANTON, Calif., Feb. 17, 2021 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG) today reported financial results for the fourth quarter and full year ended December 31, 2020 and provides outlook for full year 2021.

Introducing 10X Genomics raises $35 million for cell sequencing Home Page - 10x In this researcher spotlight, we feature an interview with Dr. Roser Vento-Tormo of the Wellcome Sanger Institute, who is using single cell and spatial solutions to This interactive virtual course will introduce participants to a new generation of a spatially resolved transcriptomics assay provided by 10x Genomics. The Visium 21 Mar 2019 Hi Elena,. Yes indeed we have been using 10X Genomics for our scRNAseq in the paper A vd Heuvel et al Hum Mol Genet 2018. 31 Jul 2020 2 Implementation of new procedures on the 10x Genomics Chromium system . the technique as a commercial service (e.g.

Cartana's patent-applied research tool revolutionizes the possibility of analyzing tissue samples, Cartana is acquired by 10x Genomics for 425 MSEK bolaget Cartana av det amerikanska biotechföretaget 10x Genomics. KI Innovations inkubatorbolag Cartana på KI Campus Solna.